Ventyx Biosciences, Inc.
VTYX
$1.07
$0.010.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.97% | 15.93% | -8.52% | -54.55% | -77.97% |
| Total Depreciation and Amortization | 43.25% | 108.72% | 153.09% | 136.38% | 100.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.63% | -23.93% | 3.69% | 28.11% | 37.31% |
| Change in Net Operating Assets | -281.93% | -9,690.43% | 45.53% | -40.15% | 212.58% |
| Cash from Operations | 21.41% | 1.76% | -4.64% | -56.65% | -68.59% |
| Capital Expenditure | 53.11% | -7.47% | -6.47% | -111.78% | -86.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -115.05% | 149.13% | 185.84% | 310.62% | 235.90% |
| Cash from Investing | -115.36% | 148.38% | 184.37% | 308.99% | 234.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.80% | 82.68% | -57.06% | -55.52% | -70.06% |
| Repurchase of Common Stock | -- | 91.25% | 91.25% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | 200.00% | 200.00% | -- |
| Cash from Financing | 128.98% | 189.52% | -55.39% | -53.37% | -68.21% |
| Foreign Exchange rate Adjustments | -358.33% | 12.20% | -400.00% | 42.19% | 71.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.28% | 102.51% | -254.02% | 260.36% | -105.38% |